Cell Signaling Technology

Product Pathways - TGF-beta/Smad Signaling

Mic-1 (Y60) Antibody #3249

Applications Reactivity Sensitivity MW (kDa) Source
W H (Mk) Endogenous 35 Rabbit

Applications Key:  W=Western Blotting
Reactivity Key:  H=Human  Mk=Monkey
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

Protocols

Specificity / Sensitivity

Mic-1 (Y60) Antibody detects endogenous levels of the precursor form of Mic-1.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponsing to residues surrounding Tyr60 of human Mic-1. Antibodies are purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from HT-1080 cells, untreated or treated with TPA, TNF-α or TGF-β (6 hrs), using Mic-1 (Y60) Antibody.

Background

Macrophage inhibitory cytokine-1 (Mic-1), also termed GDF15 (1), PTGF-β (2), PLAB (3), PDF (4), and NAG-1 (5) is a divergent member of the transforming growth factor-β (TGF-β) superfamily (6). Like other family members, Mic-1 is synthesized as an inactive precursor that undergoes proteolytic processing involving removal of an N-terminal hydrophobic signal sequence followed by cleavage at a conserved RXXR site generating an active C-terminal domain that is secreted as a dimeric protein. Mic-1 is highly expressed in the placenta and is also dramatically increased by cellular stress, acute injury, inflammation, and cancer. In the brain, Mic-1 is found in the choroid plexus and is secreted into the cerebrospinal fluid (7). It is also a transcriptional target of the p53 tumor suppressor protein and may serve as a biomarker for p53 activity (8,9). During tumor progression, Mic-1 has various effects on apoptosis, differentiation, angiogenisis, and metastasis, and may also contribute to weight loss during cancer (10,11).

  1. Strelau, J. et al. (2000) J Neurosci 20, 8597-603.
  2. Yokoyama-Kobayashi, M. et al. (1997) J Biochem 122, 622-6.
  3. Hromas, R. et al. (1997) Biochim Biophys Acta 1354, 40-4.
  4. Paralkar, V.M. et al. (1998) J Biol Chem 273, 13760-7.
  5. Baek, S.J. et al. (2001) J Biol Chem 276, 33384-92.
  6. Bootcov, M.R. et al. (1997) Proc Natl Acad Sci USA 94, 11514-9.
  7. Strelau, J. et al. (2000) J Neural Transm Suppl , 273-6.
  8. Kannan, K. et al. (2000) FEBS Lett 470, 77-82.
  9. Yang, H. et al. (2003) Mol Cancer Ther 2, 1023-9.
  10. Johnen, H. et al. (2007) Nat Med 13, 1333-40.
  11. Bauskin, A.R. et al. (2006) Cancer Res 66, 4983-6.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.

Products